Death service ratio: A measure of hospice utilization and cost impact

Journal of Pain and Symptom Management

Volumn 41, Issue 6, 2011, Pages

  Abernethy, Amy P ^a,b   Kassner, Cordt T ^c   Whitten, Elizabeth ^d   Bull, Janet ^d   Taylor Jr , Donald H ^e  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b FLINDERS UNIVERSITY   (Australia)

^c Hospice Analytics   (United States)

^d Four Seasons   (United States)

^e DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEALTH CARE COST; HEALTH CARE UTILIZATION; HOSPICE; HUMAN; LENGTH OF STAY; LETTER; MEDICARE; PALLIATIVE THERAPY; UNITED STATES;

AGED; COST CONTROL; HEALTH EXPENDITURES; HOSPICE CARE; HUMANS; LENGTH OF STAY; MEDICARE; NEOPLASMS; UNITED STATES;

EID: 79957654494     PISSN: 08853924     EISSN: 18736513     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2011.03.004     Document Type: Letter

References (2)

1. Taylor DH Jr, Ostermann J, Van Houtven CH, Tulsky JA, Steinhauser K. What length of hospice use maximizes reduction in medical expenditures near death in the US Medicare program? Soc Sci Med 2007;65:1466-1478.
2. Wachterman MW, Marcantonio ER, Davis RB, McCarthy EP. Association of hospice agency profit status with patient diagnosis, location of care, and length of stay. JAMA 2011;305:472-479.